The life-changing treatment at Great Ormond Street Hospital means Saffie can now, for the first time, see her parents’ faces ...

Coding in near darkness, guided only by sound and determination, Toh Khai Shern has achieved what once seemed impossible, ...

Three scientists have won the 2026 Breakthrough Prize for developing Luxturna — the world's first FDA-approved gene therapy ...

A brain that develops in the deprivation of one sense reorganises itself in surprising ways, revealing remarkable neuroplasticity. Researchers studied the brain activity of young congenitally deaf and ...

LOS ANGELES, April 18, 2026 /PRNewswire/ -- Their discovery started with a group of blind dogs living at a vet school. Now, the work has been awarded the prestigious Breakthrough Prize at the "Oscars ...

Mr Toh Khai Shern has about 20 per cent vision, limited to light and shadows. Read more at straitstimes.com. Read more at ...

Does the deaf brain "see" with its ears? New research shows the auditory cortex maps visual space through selective ...

Molecular biologist Jean Bennett and ophthalmologist Albert Maguire were awarded the $3 million Breakthrough Prize in Life ...

The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, ...

Luxturna was the first FDA-approved gene therapy for a disease caused by mutations in a specific gene. It helped establish ...

Six-year-old Saffie Sandford from Stevenage has regained her sight after receiving Luxturna, a first-of-its-kind NHS gene therapy for Leber's Congenital Amaurosis. The treatment involved injecting a ...

Married couple Jean Bennett and Albert Maguire developed Luxturna, which helped a patient see their child’s face for the first time ...